ZA200800516B - Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as V1a receptor antagonists - Google Patents

Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as V1a receptor antagonists

Info

Publication number
ZA200800516B
ZA200800516B ZA200800516A ZA200800516A ZA200800516B ZA 200800516 B ZA200800516 B ZA 200800516B ZA 200800516 A ZA200800516 A ZA 200800516A ZA 200800516 A ZA200800516 A ZA 200800516A ZA 200800516 B ZA200800516 B ZA 200800516B
Authority
ZA
South Africa
Prior art keywords
indol
piperidin
carbonyl
receptor antagonists
benzoimidazol
Prior art date
Application number
ZA200800516A
Inventor
Bissantz Caterina
Ratni Hasane
Schnider Patrick
Grundschober Christophe
Rogers-Evans Mark
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA200800516B publication Critical patent/ZA200800516B/en

Links

ZA200800516A 2005-07-21 2008-01-17 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as V1a receptor antagonists ZA200800516B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05106695 2005-07-21

Publications (1)

Publication Number Publication Date
ZA200800516B true ZA200800516B (en) 2008-12-31

Family

ID=39989793

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200800516A ZA200800516B (en) 2005-07-21 2008-01-17 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as V1a receptor antagonists

Country Status (1)

Country Link
ZA (1) ZA200800516B (en)

Similar Documents

Publication Publication Date Title
IL188478A0 (en) Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists
ZA200800353B (en) Pyrazine derivatives useful as adenosine receptor antagonists
AP2006003840A0 (en) Indole-2-carboxamidine derivatives as NMDA receptor antagonists
ZA200708028B (en) Acetylenyl-pyrazolo-pyrimidine derivatives as mGluR2 antagonists
GB0509275D0 (en) Synthetic receptor
EP2058304A4 (en) P2x4 receptor antagonist
IL184816A0 (en) 2-phenyl-indoles as prostaglandin d2 receptor antagonists
AP2007004047A0 (en) Substituted triazole derivatives as oxtocin antagonists
AP2008004441A0 (en) Piperdin-4-ylpyrazin-2-ylamine derivatives as fastdissociating dopamine 2 receptor antagonists
IL186188A0 (en) Pyrimidindione derivatives as prokineticin 2 receptor antagonists
IL190152A0 (en) Indane derivatives as mch receptor antagonists
AP1983A (en) Carboxamide derivatives as muscarinic receptor antagonists
IL192308A0 (en) Oxazoloisoquinoline derivatives as thrombin receptor antagonists
PT1912976E (en) Indol-3-yl-carbonyl-piperidin-benzoimidazole derivatives as v1a receptor antagonists
GB0509276D0 (en) Synthetic receptor
HUP0501169A3 (en) New phenantridine derivatives as selective bradykinin b1 receptor antagonists
ZA200802339B (en) Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
ZA200903496B (en) Spiro-piperidine derivatives as via receptor antagonists
GB0525029D0 (en) Receptor Antagonist
ZA200800516B (en) Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as V1a receptor antagonists
GB0516946D0 (en) Receptor
GB0516617D0 (en) EP2 Receptor antagonists
GB0522484D0 (en) Receptor
GB0522394D0 (en) Receptor
GB0522077D0 (en) Receptor